Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Preliminary definition of improvement in juvenile arthritis.

Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A.

Arthritis Rheum. 1997 Jul;40(7):1202-9.

PMID:
9214419
2.

Minimal disease activity for rheumatoid arthritis: a preliminary definition.

Wells GA, Boers M, Shea B, Brooks PM, Simon LS, Strand CV, Aletaha D, Anderson JJ, Bombardier C, Dougados M, Emery P, Felson DT, Fransen J, Furst DE, Hazes JM, Johnson KR, Kirwan JR, Landewé RB, Lassere MN, Michaud K, Suarez-Almazor M, Silman AJ, Smolen JS, Van der Heijde DM, van Riel PL, Wolfe F, Tugwell PS.

J Rheumatol. 2005 Oct;32(10):2016-24.

PMID:
16206362
3.

International consensus on preliminary definitions of improvement in adult and juvenile myositis.

Rider LG, Giannini EH, Brunner HI, Ruperto N, James-Newton L, Reed AM, Lachenbruch PA, Miller FW; International Myositis Assessment and Clinical Studies Group.

Arthritis Rheum. 2004 Jul;50(7):2281-90. Review.

4.

The Paediatric Rheumatology International Trials Organization (PRINTO).

Ruperto N, Bazso A, Ravelli A, Malattia C, Filocamo G, Pistorio A, Rodriguez Lozano AL, Viola S, Martini A; Paediatric Rheumatology International Trials Organization (PRINTO).

Lupus. 2007;16(8):670-6. Review.

PMID:
17711906
5.

Defining Clinical Improvement in Adult and Juvenile Myositis.

Rider LG, Giannini EH, Harris-Love M, Joe G, Isenberg D, Pilkington C, Lachenbruch PA, Miller FW; International Myositis Assesment and Clinical Studies Group.

J Rheumatol. 2003 Mar;30(3):603-17. Review.

PMID:
12610824
6.

The measurement and monitoring of surgical adverse events.

Bruce J, Russell EM, Mollison J, Krukowski ZH.

Health Technol Assess. 2001;5(22):1-194. Review.

7.

A method for achieving consensus on rheumatoid arthritis outcome measures: the OMERACT conference process.

Fried BJ, Boers M, Baker PR.

J Rheumatol. 1993 Mar;20(3):548-51. Review.

PMID:
8478870
8.

Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis.

Ruperto N, Ravelli A, Murray KJ, Lovell DJ, Andersson-Gare B, Feldman BM, Garay S, Kuis W, Machado C, Pachman L, Prieur AM, Rider LG, Silverman E, Tsitsami E, Woo P, Giannini EH, Martini A; Paediatric Rheumatology International Trials Organization (PRINTO); Pediatric Rheumatology Collaborative Study Group (PRCSG).

Rheumatology (Oxford). 2003 Dec;42(12):1452-9. Epub 2003 Jun 27. Review.

PMID:
12832713
9.

The Italian Consensus Conference on Diagnostic Criteria for Myelofibrosis with Myeloid Metaplasia.

Barosi G, Ambrosetti A, Finelli C, Grossi A, Leoni P, Liberato NL, Petti MC, Pogliani E, Ricetti M, Rupoli S, Visani G, Tura S.

Br J Haematol. 1999 Mar;104(4):730-7. Review.

PMID:
10192432
10.

Outcome in pediatric rheumatic disease.

Graham TB, Lovell DJ.

Curr Opin Rheumatol. 1997 Sep;9(5):434-9. Review.

PMID:
9309199
11.

Quantitative measures for assessing rheumatoid arthritis in clinical trials and clinical care.

Pincus T, Sokka T.

Best Pract Res Clin Rheumatol. 2003 Oct;17(5):753-81. Review.

PMID:
12915156
12.

Nonsomatic treatment of depression.

Sherrill JT, Kovacs M.

Child Adolesc Psychiatr Clin N Am. 2002 Jul;11(3):579-93. Review.

PMID:
12222084
13.

Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.

Keam SJ, Keating GM.

Treat Respir Med. 2004;3(4):247-68. Review.

PMID:
15350163
14.

How does one assess early rheumatoid arthritis in daily clinical practice?

van Riel PL, Schumacher HR Jr.

Best Pract Res Clin Rheumatol. 2001 Mar;15(1):67-76. Review.

PMID:
11358415
15.

Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.

Woolacott N, Bravo Vergel Y, Hawkins N, Kainth A, Khadjesari Z, Misso K, Light K, Asseburg C, Palmer S, Claxton K, Bruce I, Sculpher M, Riemsma R.

Health Technol Assess. 2006 Sep;10(31):iii-iv, xiii-xvi, 1-239. Review.

16.

The Pediatric Rheumatology European Society/American College of Rheumatology/European League against Rheumatism provisional classification criteria for juvenile systemic sclerosis.

Zulian F, Woo P, Athreya BH, Laxer RM, Medsger TA Jr, Lehman TJ, Cerinic MM, Martini G, Ravelli A, Russo R, Cuttica R, de Oliveira SK, Denton CP, Cozzi F, Foeldvari I, Ruperto N.

Arthritis Rheum. 2007 Mar 15;57(2):203-12.

17.

The clinical features of rheumatoid arthritis.

Grassi W, De Angelis R, Lamanna G, Cervini C.

Eur J Radiol. 1998 May;27 Suppl 1:S18-24. Review.

PMID:
9652497
18.

2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.

Aggarwal R, Rider LG, Ruperto N, Bayat N, Erman B, Feldman BM, Oddis CV, Amato AA, Chinoy H, Cooper RG, Dastmalchi M, Fiorentino D, Isenberg D, Katz JD, Mammen A, de Visser M, Ytterberg SR, Lundberg IE, Chung L, Danko K, García-De la Torre I, Song YW, Villa L, Rinaldi M, Rockette H, Lachenbruch PA, Miller FW, Vencovsky J; International Myositis Assessment and Clinical Studies Group and the Paediatric Rheumatology International Trials Organisation.

Ann Rheum Dis. 2017 May;76(5):792-801. doi: 10.1136/annrheumdis-2017-211400.

PMID:
28385805
19.

Criteria to define response to therapy in paediatric rheumatic diseases.

Ruperto N, Pistorio A, Ravelli A, Hasija R, Guseinova D, Filocamo G, Demirkaya E, Malattia C, Martini A; Paediatric Rheumatology International Trials Organisation (PRINTO).

Eur J Clin Pharmacol. 2011 May;67 Suppl 1:125-31. doi: 10.1007/s00228-010-0937-8. Epub 2010 Nov 20. Review.

PMID:
21103985

Supplemental Content

Support Center